Thursday, February 9, 2023
News

Alembic Pharma gets US regulator final nod for skin ointment - Desonide Cream

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi | December 9, 2022 2:31:39 PM IST
Alembic Pharmaceuticals (Alembic) on Friday announced that it received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) -- Desonide Cream, 0.05 per cent, an ointment used for the treatment of skin conditions.

According to a statement from the Vadodara-headquartered pharma firm, the ANDA was filed by Aleor Dermaceuticals (Aleor) which was amalgamated with Alembic. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Desonide Cream, 0.05 per cent, of Padagis US LLC.

Desonide Cream, 0.05 per cent, is a low-potency corticosteroid indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Desonide Cream, 0.05 per cent, has an estimated market size of USD 12 million for twelve months ending September 2022, according to pharma firm IQVIA.

Alembic has received a cumulative total of 178 ANDA approvals (155 final approvals and 23 tentative approvals) from USFDA.

An abbreviated new drug application (ANDA) is an application for a US generic drug approval for an existing licensed medication or approved drug.

According to the statement, Alembic Pharmaceuticals, a vertically integrated research and development (R-D) pharmaceutical company, has been at the forefront of health care since 1907.

Alembic is a publicly-listed company that manufactures and markets generic pharmaceutical products across the world. Alembic's latest R-D facilities are approved by regulatory authorities of many developed countries, including the USFDA. (ANI)

 
  LATEST COMMENTS ()
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE BUSINESS NEWS
Mumbai-based financial intermediary, Fin...
WinWire welcomes John Castleman to its B...
Design students of Woxsen University &am...
LexisNexis Risk Solutions launches first...
Uniphore acquires France-based Hexagone...
Safer Internet Day 2023: CyberPeace laun...
More...
 
INDIA WORLD ASIA
Tension during Lokesh's padyatra in Chit...
Over 4,000 youths cheated on pretext of ...
Delhi HC grants bail to alleged kingpin ...
Goa House Committee discusses Mhadei iss...
Four held for killing a man in Delhi...
BJP's activities in Bengal restricted to...
More...    
 
 Top Stories
Credit Suisse buys Klein & Co f... 
From Gamers to Game Designers: Edol... 
Siddharth Bathla - Revolutionising ... 
Talligence - a unique AI & ML p... 
Radhe Dhokla launches Sevanand init... 
Tribals were deprived of developmen... 
Ravichandran Ashwin becomes second ... 
Kerala police detains BJP workers p...